Wolverine Trading’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,120
Closed -$244K 2297
2025
Q1
$244K Sell
6,120
-34,627
-85% -$1.38M ﹤0.01% 978
2024
Q4
$1.28M Buy
40,747
+28,468
+232% +$895K ﹤0.01% 488
2024
Q3
$293K Sell
12,279
-2,483
-17% -$59.2K ﹤0.01% 902
2024
Q2
$263K Sell
14,762
-29,478
-67% -$524K ﹤0.01% 917
2024
Q1
$673K Buy
+44,240
New +$673K ﹤0.01% 536
2023
Q4
Sell
-24,155
Closed -$202K 2143
2023
Q3
$202K Sell
24,155
-3,744
-13% -$31.3K ﹤0.01% 922
2023
Q2
$673K Buy
+27,899
New +$673K ﹤0.01% 438
2023
Q1
Hold
0
2052
2022
Q4
Hold
0
2068
2022
Q3
Hold
0
2195
2022
Q2
Sell
-13,720
Closed -$135K 2284
2022
Q1
$135K Sell
13,720
-10,008
-42% -$98.5K ﹤0.01% 1278
2021
Q4
$459K Sell
23,728
-606
-2% -$11.7K ﹤0.01% 903
2021
Q3
$817K Sell
24,334
-5,725
-19% -$192K ﹤0.01% 765
2021
Q2
$1.13M Buy
30,059
+760
+3% +$28.6K ﹤0.01% 566
2021
Q1
$1.33M Sell
29,299
-56,930
-66% -$2.58M ﹤0.01% 504
2020
Q4
$4.56M Sell
86,229
-8,573
-9% -$453K 0.01% 161
2020
Q3
$2.48M Buy
94,802
+14,387
+18% +$377K 0.01% 190
2020
Q2
$1.49M Sell
80,415
-23,003
-22% -$427K ﹤0.01% 255
2020
Q1
$1.07M Buy
103,418
+942
+0.9% +$9.72K ﹤0.01% 383
2019
Q4
$1.11M Buy
102,476
+2,619
+3% +$28.4K ﹤0.01% 620
2019
Q3
$564K Buy
99,857
+19,764
+25% +$112K ﹤0.01% 579
2019
Q2
$693K Sell
80,093
-61,208
-43% -$530K ﹤0.01% 499
2019
Q1
$1.14M Buy
141,301
+68,171
+93% +$548K ﹤0.01% 326
2018
Q4
$291K Buy
73,130
+25,295
+53% +$101K ﹤0.01% 868
2018
Q3
$268K Buy
47,835
+29,009
+154% +$163K ﹤0.01% 1112
2018
Q2
$267K Hold
18,826
﹤0.01% 976
2018
Q1
$267K Buy
+18,826
New +$267K ﹤0.01% 976
2017
Q4
Hold
0
2089
2017
Q3
Sell
-45,150
Closed -$479K 1925
2017
Q2
$479K Buy
+45,150
New +$479K ﹤0.01% 604
2017
Q1
Sell
-12,090
Closed -$56K 1942
2016
Q4
$56K Buy
+12,090
New +$56K ﹤0.01% 1086
2016
Q3
Sell
-12,055
Closed -$72K 1931
2016
Q2
$72K Buy
+12,055
New +$72K ﹤0.01% 803